JPH0495052A - Extraction and production of terpene derivative - Google Patents

Extraction and production of terpene derivative

Info

Publication number
JPH0495052A
JPH0495052A JP21354990A JP21354990A JPH0495052A JP H0495052 A JPH0495052 A JP H0495052A JP 21354990 A JP21354990 A JP 21354990A JP 21354990 A JP21354990 A JP 21354990A JP H0495052 A JPH0495052 A JP H0495052A
Authority
JP
Japan
Prior art keywords
solvent
terpene derivative
give
high performance
performance liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21354990A
Other languages
Japanese (ja)
Inventor
Kengo Shiba
柴 賢悟
Isao Kitagawa
北川 勲
Hideo Koizumi
小泉 英男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHINISE KEIMEIDOU KK
Original Assignee
SHINISE KEIMEIDOU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHINISE KEIMEIDOU KK filed Critical SHINISE KEIMEIDOU KK
Priority to JP21354990A priority Critical patent/JPH0495052A/en
Publication of JPH0495052A publication Critical patent/JPH0495052A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NEW MATERIAL:A terpene derivative shown by the formula, namely (2s)-8- benzoyloxy-2,6-(1-methylethylidene)-5-cyclodecane-1. USE:A drug such as anti-inflammatory drug. PREPARATION:Zedoariae Rhizoma is immersed in an organic solvent, the extracted solution is concentrated to give essence. The essence is treated by column chromatography and high performance liquid chromatography, then dehydrourdione fractionated and crystallized with an organic solvent is reduced to give a solution of (2s)-8-hydroxy-2,6-dimethyl-9-(1-methylethylidene)-5- cyclodecen-1-one in pyridine, which is mixed with benzoyl chloride and stirred. Then the resulting material is extracted with ethyl acetate, the solvent is distilled away under reduced pressure to give a crude substance. The substance is separated and purified by high performance liquid chromatography to give a terpene derivative shown by the formula.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は下記構造式(1) で示される新規なテルペン誘導体(2S)−8−ben
zoyloxy−2,6(1−+*eLhylethy
lidene)−5−cyclodecane−1に閏
る。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a novel terpene derivative (2S)-8-ben represented by the following structural formula (1).
zoyloxy-2,6(1-+*eLhylethy
lidene)-5-cyclodecane-1.

従来の技術 生薬のガジュツ[筏求、学名・ゼドアリアリゾーマ(Z
ecloariae Rhizoma) 、ショウガ科
〕は古くから芳香性健胃薬として消化器系疾患に使用さ
れており、その成分にはシネオール、セスキテルペンア
ルコール、カンフエン等を含む精油、その他の脂肪油、
澱粉質、粘着質及びゴム質等を含むものであることが、
例えば時開57163373号公報に記載されている。
Conventional technology Herbal medicine gajutsu
ecloariae Rhizoma), Zingiberaceae] has been used as an aromatic stomachic for digestive system diseases since ancient times, and its ingredients include essential oils including cineole, sesquiterpene alcohol, camphuene, etc., as well as other fatty oils,
Contains starchy, sticky, rubbery, etc.
For example, it is described in Jikai No. 57163373.

又、このような生薬としてのガジュツがらはフラノゲル
メノンと命名されたセスキテルペノイド誘導体が羊離さ
れ、抗肝炎作用のあることが見出されており、これらの
ことも上記公開公報に示され、更に抗潰瘍作用のあるこ
とが特開昭61−227523号公報に記載されている
In addition, a sesquiterpenoid derivative named furanogermenone has been isolated from zeju as a herbal medicine and has been found to have antihepatitis effects, and these facts are also shown in the above-mentioned publication, Furthermore, it is described in JP-A No. 61-227523 that it has an anti-ulcer effect.

又、(4S、5S)−(÷)−ゲルマクロン4.5エポ
キサイドがガジュツがら単離され、これも抗潰瘍作用の
あることが特rff461−227575号公報に記載
されている。
Further, (4S,5S)-(÷)-germacrone 4.5 epoxide was isolated from Gejutsu, and it is described in Japanese Patent No. RFF461-227575 that this also has anti-ulcer effect.

加えて既に、Chem、Pharm、Bull 20(
5)987(+972) H9Ilikino等により
、デヒドロクロジオンと命名されたセキステルペノイド
誘導体の存在が知られている。
In addition, Chem, Pharm, Bull 20 (
5) 987 (+972) H9 The existence of a sexterpenoid derivative named dehydroclodione by Ilikino et al. is known.

発明が解決しようとする問題点 現在まで、右記に示す構造式(1)の誘導体発明が解決
使用とする手段 本発明は上記問題点を解決する為に、下記の構造式(1
)で構造式(1) 示されるテルペン誘導体を提供するものである。
Problems to be Solved by the Invention Until now, the means to be solved by the derivative invention of the structural formula (1) shown on the right The present invention has solved the above-mentioned problems.
) provides a terpene derivative represented by structural formula (1).

又、ガジュツを有機溶媒に浸出し、その抽出液を濃縮し
て得られるエキスをカラムクロマトグラフィー及び高速
液体クロマトグラフィー法で分離結晶化したデヒドロク
ルジオンを還元して出来fS物質のピリジン溶液に塩化
ベンゾイルを加え撹拌し酢酸エチルて′抽出する。
In addition, the extract obtained by leaching zejutsu into an organic solvent and concentrating the extract was separated by column chromatography and high performance liquid chromatography, and the crystallized dehydrocurdione was reduced to a pyridine solution of the resulting fS substance. Add benzoyl, stir, and extract with ethyl acetate.

その溶媒を減圧留去して得た粗生成物を液体クロマトグ
ラフィで分離精製することにより上記の構造式(1)で
示される化合物を得ることを特徴とするテルペン誘導体
の抽出法及び製造法を提供するものである。
Provided is a method for extracting and producing a terpene derivative, characterized in that a compound represented by the above structural formula (1) is obtained by separating and purifying the crude product obtained by distilling off the solvent under reduced pressure using liquid chromatography. It is something to do.

上記構造式(1)のテルペン誘導体は、ガジュツの有機
溶媒抽出液から得られるエキスをメタノールとヘキサン
により分配抽出し、そのヘキサン層をカラムクロマトグ
ラフィーにより分別することにより得られたデヒドロク
ルジオンに水素化ホウ素ナトリウムで還元して得られた
物質のピリジン溶液に塩化ベンゾイルを加え、撹拌後酢
酸エチルで抽出する。
The terpene derivative of the above structural formula (1) is obtained by distributing the extract obtained from the organic solvent extract of Gajutu with methanol and hexane, and separating the hexane layer by column chromatography. Benzoyl chloride is added to a pyridine solution of the substance obtained by reduction with sodium boronate, and after stirring, the mixture is extracted with ethyl acetate.

得られた有機層を塩酸水溶液、飽和炭酸水素ナトリウム
水溶液、飽和塩化ナトリウム水溶液で洗浄刷る。硫酸マ
グネシウムで乾燥後、溶媒を減圧留去して得られた粗生
成物を高速液体クロマトグラフィーで分離精製して上記
(1)の誘導体が得られる。
The obtained organic layer is washed with an aqueous hydrochloric acid solution, a saturated aqueous sodium bicarbonate solution, and a saturated aqueous sodium chloride solution. After drying with magnesium sulfate, the solvent is distilled off under reduced pressure, and the resulting crude product is separated and purified using high performance liquid chromatography to obtain the derivative (1) above.

しかし、デヒドロクルジオンの還元物質にピリジン溶液
を加えるが、これは他の有機塩基でもかまわない。
However, a pyridine solution is added to the reducing substance of dehydrocludione, but other organic bases may also be used.

又、撹拌後酢酸エチルで抽出するが、これも他の有機溶
媒でも可能である。抽出後、粗生成物を分離精製を行う
には高速液体クロマトグラフィー及びカラムクロマトグ
ラフィー法を用いる事が好ましい。
Further, after stirring, extraction is performed with ethyl acetate, but this can also be done with other organic solvents. After extraction, it is preferable to use high performance liquid chromatography and column chromatography to separate and purify the crude product.

しかし、その場合いずれの場合でも担体にはシリカゲル
を用いn−ヘキサンと酢酸エチルの混合溶媒を混合比を
20=1にして行ったが、混合比はこれに限らない。
However, in all cases, silica gel was used as the carrier and a mixed solvent of n-hexane and ethyl acetate was mixed at a mixing ratio of 20=1, but the mixing ratio is not limited to this.

以上により単離された上記構造式(1)の誘導体の物理
化学的性質は以下に記載の通りである。
The physicochemical properties of the above-isolated derivative of structural formula (1) are as described below.

■臭いは無く、無色油状物である。■It has no odor and is a colorless oil.

■元素分析値:c22112go) 計算値 Cニア7.6HH:8.29$実m値Cニア7
.49$   ll:8.171■(α)%’−149
°(C=1.03 、 りooホルム)の比旋光度を有
する。
■Elemental analysis value: c22112go) Calculated value C near 7.6HH: 8.29$ Actual m value C near 7
.. 49$ ll: 8.171■(α)%'-149
It has a specific optical rotation of ° (C=1.03, rioo form).

■円二色性スペクトル(メタノール):〔θ)2.2−
270.74(neH,纏ax  :c=o  )(0
)zz+−753,55(neg、wux)を示した。
■Circular dichroism spectrum (methanol): [θ)2.2-
270.74 (neH, Mato ax :c=o)(0
)zz+-753,55 (neg, wux).

■紫外線吸収スペクトルは(メタノ一ル、 n m (
logε)):228(29262,4,47> 273(1917,3,28) 281(1519,3,18) を示した。
■The ultraviolet absorption spectrum is (methanol, nm (
logε)): 228 (29262, 4, 47> 273 (1917, 3, 28) 281 (1519, 3, 18).

■赤外線吸収スペクトルはくクロロホルム、 c m−
’):1708 GC=0)を示した。
■Infrared absorption spectrum: Chloroform, cm-
'):1708 GC=0).

■水素核磁気共鳴スペクトル(90MHz 、CDCL
、 、 (ppm)1.10(3H,d 、JニアHz
、2−He)1.75.1.79.1.97(3H,e
+sch、alls)3.13.3.44(2B、^B
q、J:17Hz、1O−Hz5.12.(IHt、J
=7Hz、5−H2)6.10(IH,dd、J:6.
6Hz 8−41)7.3〜7.6(30,m、3′4
1.4’−H2S”−11)7.9〜8.3(211,
2′−H,6′−H)を示す。
■Hydrogen nuclear magnetic resonance spectrum (90MHz, CDCL)
, , (ppm) 1.10 (3H, d, J near Hz
,2-He)1.75.1.79.1.97(3H,e
+sch, alls) 3.13.3.44 (2B, ^B
q, J: 17Hz, 1O-Hz5.12. (IHt, J
=7Hz, 5-H2) 6.10 (IH, dd, J:6.
6Hz 8-41) 7.3-7.6 (30, m, 3'4
1.4'-H2S"-11) 7.9-8.3 (211,
2'-H, 6'-H).

発明の効果 前項の説明により本発明によれば、従来にない新規のテ
ルペン誘導体を製造出来るので、例えば抗炎症剤等の医
薬品として提供できる。
Effects of the Invention As explained in the previous section, according to the present invention, a novel terpene derivative that has not been seen before can be produced, so that it can be provided as a pharmaceutical such as an anti-inflammatory agent.

又、この新規の誘導体は生薬を原料として用いることも
出来るので、容易に得られ易く、更に製造法も従来の分
離精製手段を利用出来るため容易である。
In addition, this new derivative can be easily obtained because it can use crude drugs as raw materials, and the manufacturing method is also easy because conventional separation and purification means can be used.

実施例 以下実施例に基づいて詳細を説明する。Example Details will be explained below based on examples.

ショウガ科生薬ガジュツの乾燥薄片(10,8kg)を
メタノール(201)で7時間温浸(水浴、50℃)抽
出する。
Dried thin pieces (10.8 kg) of ginger, an herbal medicine, were extracted by digestion (water bath, 50° C.) with methanol (201) for 7 hours.

同様の操作を9回繰り返し、メタノール抽出液は合し減
圧下に溶媒を留去してメタノール抽出エキス(YK−1
と略称する、収量1.12kg、生薬からの収率10.
4$)を得た。
The same operation was repeated 9 times, the methanol extracts were combined, the solvent was distilled off under reduced pressure, and the methanol extract (YK-1
Yield: 1.12 kg, Yield from crude drug: 10.
4$).

YK−1(20(Ig)をメタノール(600儀l)に
溶解し、ヘキサン(31)で3[i]抽出する。
Dissolve YK-1 (20 (Ig)) in methanol (600 liters) and extract 3[i] with hexane (31).

残りのYK−1の一部(800g>も同様にメタノール
−ヘキサンで分配抽出する。
A portion of the remaining YK-1 (>800 g) is similarly partitioned and extracted with methanol-hexane.

メタノール層は合して減圧下に溶媒を留去し、メタノー
ル層エキス(YK−2,680g、 7.1りを得た。
The methanol layers were combined and the solvent was distilled off under reduced pressure to obtain a methanol layer extract (YK-2, 680 g, 7.1).

ヘキサン層は合して減圧上溶媒を留去し、ヘキサン層エ
キス(YK3.310g、 3.2g)を得た。
The hexane layers were combined and the solvent was distilled off under reduced pressure to obtain a hexane layer extract (YK 3.310 g, 3.2 g).

YK−3(100g>をシリカゲルカラムクロマトグラ
フィー〔シリカゲル3.0kg(MERCK社製、Ki
eselgel 60))、溶出溶媒:(1)ヘキサン
#酸エチル系(ヘキサン:酢酸エチル・50:1.20
:1.15:1.10:1゜8:l、の順で各20/)
、(2)クロロホルム−メタノール系(クロロホルム:
メタノール=10:1. O:100の順で各8N)を
用いて分画くYに−4〜8)する。
YK-3 (100g) was subjected to silica gel column chromatography [silica gel 3.0kg (MERCK, Ki
eselgel 60)), elution solvent: (1) hexane/ethyl acetate system (hexane:ethyl acetate, 50:1.20
:1.15:1.10:1゜8:l, each 20/)
, (2) Chloroform-methanol system (chloroform:
Methanol = 10:1. Fractionate into Y-4 to 8) using 8N) in the order of O:100.

即ち、ヘキサン:酢酸エチル・20:1の溶出溶媒から
の溶出部の溶媒を減圧下に留去して第4分画YK−4(
23,3g、 0.75$)を得た。
That is, the solvent of the eluate from the elution solvent of hexane:ethyl acetate 20:1 was distilled off under reduced pressure to obtain the fourth fraction YK-4 (
23.3g, 0.75$) was obtained.

同様にヘキサン:酢酸エチル=15:1.10:1.8
:1の各溶出溶媒による溶出部からの第5分画(YK−
5,14,3g、 0.46$)、第6分画(YK−6
,11,8g、 0.38$)、第7分画(YK−7,
6,5g、0.211)、クロ0ホルム:メタノール=
10:1溶出部から第8分画(YK−8,22,9g。
Similarly, hexane: ethyl acetate = 15:1.10:1.8
:5th fraction from the elution area with each elution solvent of 1 (YK-
5,14,3g, 0.46$), 6th fraction (YK-6
, 11.8g, 0.38$), 7th fraction (YK-7,
6.5g, 0.211), chloroform:methanol=
8th fraction from the 10:1 elution area (YK-8, 22.9 g.

0.74$)を、それぞれ得た。0.74$) were obtained, respectively.

YK−5の溶媒を減圧下に留去し、無色板状結晶のセス
キテルペノイド化合物(デヒドロクルジオン)を得た。
The solvent of YK-5 was distilled off under reduced pressure to obtain a sesquiterpenoid compound (dehydrocludione) in the form of colorless plate-like crystals.

このデヒドロクルジオン(300mg)のメタノール(
20mZ)溶液に塩化セリウム、7水和物(477,7
mg)及び水素化ホウ素ナトリウム(48,5mg>を
加え、室温で30分撹拌した。
methanol (
Cerium chloride, heptahydrate (477,7
mg) and sodium borohydride (48.5 mg>) were added and stirred at room temperature for 30 minutes.

希硫酸水溶液で中和後、酢酸エチルで3回抽出し、得ら
れた有機層を飽和炭酸水素ナトリウム水溶液及び飽和塩
化ナトリウム水溶液で洗浄する。硫酸マグネシウムで乾
燥後、溶媒を減圧留去して、粗生成物(275,hg)
が得られる。この粗生成物をシリカゲルカラムクロマト
グラフィー(S、Ox 2Bg、ヘキサン:酢酸エチル
=5:1)で分離精製して(2S)−8−hydrox
y−2,6−dimethyl−9−(1−methy
lethyl idene)−5−eyclodece
n−1−one(216sg、711)が得られる。
After neutralization with a dilute aqueous sulfuric acid solution, the mixture is extracted three times with ethyl acetate, and the resulting organic layer is washed with a saturated aqueous sodium bicarbonate solution and a saturated aqueous sodium chloride solution. After drying with magnesium sulfate, the solvent was distilled off under reduced pressure to obtain a crude product (275, hg).
is obtained. This crude product was separated and purified by silica gel column chromatography (S, Ox 2Bg, hexane: ethyl acetate = 5:1), and (2S)-8-hydrox
y-2,6-dimethyl-9-(1-methy
ethyl idene)-5-eyclodec
n-1-one (216sg, 711) is obtained.

このテルペン誘導体(35,9−g)のピリジン<3.
5d)溶液に塩ベンゾイル(0,1d)を加え、室温で
30分間撹拌した後、試薬の加水分解の為、氷水にあけ
、酢酸エチルで3回抽出した。得られた有機層を51塩
酸水溶液(3回)、飽和炭酸水素ナトリウム水溶液(2
回)、飽和塩化ナトリウム水溶液(2回)で洗浄した。
Pyridine of this terpene derivative (35,9-g) <3.
5d) Benzoyl salt (0,1d) was added to the solution, and after stirring at room temperature for 30 minutes, it was poured into ice water for hydrolysis of the reagent, and extracted three times with ethyl acetate. The obtained organic layer was mixed with 51 aqueous hydrochloric acid solution (3 times) and saturated aqueous sodium hydrogen carbonate solution (2 times).
Washed with saturated aqueous sodium chloride solution (twice).

[Mマグネシウムで乾燥後、溶媒を減圧留去して粗生成
物(118,3mg)を得な。
[After drying with magnesium magnesium, the solvent was distilled off under reduced pressure to obtain a crude product (118.3 mg).

粗生成物は高速液体クロマトグラフィー(カラム:ZO
RBAXSIL 9.4X 250s−ヘキサン:酢酸
エチル20:1)で分離精製して(2S)−8−ben
zoyfoxy−2,6−dimethyl−9−(1
−sethylethyl 1cliene)−5−e
yelodeeen−1−one(37,5mg、73
1)を得た。このようにして得られたテルペン誘導体の
物理・化学的性質は前記の通りであった。
The crude product was purified by high performance liquid chromatography (column: ZO
RBAXSIL 9.4X 250s-hexane:ethyl acetate 20:1) to separate and purify (2S)-8-ben
zoyfoxy-2,6-dimethyl-9-(1
-sethylethyl 1cliene) -5-e
yelodeeen-1-one (37.5mg, 73
1) was obtained. The physical and chemical properties of the terpene derivative thus obtained were as described above.

Claims (2)

【特許請求の範囲】[Claims] (1)下記の構造式(1)で示されるテルペン誘導体▲
数式、化学式、表等があります▼
(1) Terpene derivative represented by the following structural formula (1) ▲
Contains mathematical formulas, chemical formulas, tables, etc.▼
(2)ガジュツを有機溶媒に浸出し、その抽出液を濃縮
して得られるエキスをカラムクロマトグラフィー及び高
速液体クロマトグラフィー法を使用し、ついで有機溶媒
より分別結晶化されたデヒドロクルジオンの還元より得
られた(2S)−8−hydroxy−2,6−dim
ethyl−9−(l−methylethylidi
ene)−5−cyclodecen−1−oneのピ
リジン溶液に塩化ベンゾイルを加え撹拌後、酢酸エチル
で抽出し、溶媒を減圧留去した粗生成物を高速液体クロ
マトグラフィーで分離精製して下記の構造式(1)で示
されるテルペン誘導体を得るとを特徴とする製造法。 ▲数式、化学式、表等があります▼
(2) The extract obtained by leaching zejutsu into an organic solvent and concentrating the extract was obtained by column chromatography and high performance liquid chromatography, and then by reduction of dehydrocludion, which was fractionally crystallized from the organic solvent. The obtained (2S)-8-hydroxy-2,6-dim
ethyl-9-(l-methylethylidi
Benzoyl chloride was added to a pyridine solution of ene)-5-cyclodecen-1-one, stirred, extracted with ethyl acetate, and the solvent was distilled off under reduced pressure. The crude product was separated and purified by high performance liquid chromatography to obtain the following structural formula. A production method characterized by obtaining the terpene derivative represented by (1). ▲Contains mathematical formulas, chemical formulas, tables, etc.▼
JP21354990A 1990-08-12 1990-08-12 Extraction and production of terpene derivative Pending JPH0495052A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21354990A JPH0495052A (en) 1990-08-12 1990-08-12 Extraction and production of terpene derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21354990A JPH0495052A (en) 1990-08-12 1990-08-12 Extraction and production of terpene derivative

Publications (1)

Publication Number Publication Date
JPH0495052A true JPH0495052A (en) 1992-03-27

Family

ID=16641043

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21354990A Pending JPH0495052A (en) 1990-08-12 1990-08-12 Extraction and production of terpene derivative

Country Status (1)

Country Link
JP (1) JPH0495052A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105439913A (en) * 2015-11-18 2016-03-30 广东药学院 Germacrone derivative as well as preparation method and application thereof
CN108752210A (en) * 2018-05-14 2018-11-06 东南大学成贤学院 A kind of preparation method of germacrone ketobutyric acid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105439913A (en) * 2015-11-18 2016-03-30 广东药学院 Germacrone derivative as well as preparation method and application thereof
CN105439913B (en) * 2015-11-18 2017-09-05 广东药科大学 A kind of germacrone derivative and its preparation method and application
CN108752210A (en) * 2018-05-14 2018-11-06 东南大学成贤学院 A kind of preparation method of germacrone ketobutyric acid

Similar Documents

Publication Publication Date Title
ZA200103330B (en) Method of preparing delta-9-tetrahydrocannabinol.
JPH03264533A (en) Cencentrate of effective component of ginkgo biloba and combination of novel effective component, its preparation and drug
JP2005515238A (en) Method for preparing Δ-9-tetrahydrocannabinol
AU728188B2 (en) A process for the simultaneous production of artemisnin and essential oil from the plant artemisia annua
CN107298642B (en) Extraction and purification method of 6-shogaol
JPH0873396A (en) Lipid having high natural menaquinone-7 content
EP0908460B1 (en) A process for the simultaneous production of artemisinin and essential oil from the plant artemisia annua
González et al. Chemical constituents of the lichen Ramalina hierrensis
Torrance et al. New monoterpenes from Artemisia filifolla. Structure, synthesis, rearrangements and biosynthesis
Horn et al. Transformation of naturally-occurring 1, 9-trans-9, 5-cis sweroside to all trans sweroside during acetylation of sweroside aglycone
JPH0495052A (en) Extraction and production of terpene derivative
CN109535157B (en) Paracetamol analog, and synthesis method and application thereof
JPH0327538B2 (en)
AU2002348729B2 (en) Process for crystallization of oryzanol from oryzanol enriched fraction derived from rice bran oil soap stock
JPH04208274A (en) Extraction of terpene derivative and production thereof
JPH04208273A (en) Extraction of terpene derivative and production thereof
JPS61501147A (en) 1α,25-dihydroxy-22Z-dehydrovitamin D compound
HU180710B (en) Equipment for the isolation by extraction of natural terpenes active against psoriasis from leaves and rhizomes of fern and for preparing pharmaceutical compositions from the extract
JPH04208244A (en) Extracting method of terpene derivative and production thereof
JPS58150584A (en) Kuwanon compound
JPH0495050A (en) Extraction and production of terpene derivative
JPH04208245A (en) Extracting method of terpene derivative and production thereof
JPH021824B2 (en)
JP2585661B2 (en) Terpene compound and method for producing the same
CN103211822B (en) A kind of purposes of the suppression lipase of sterol derivative